MALT
Showing 26 - 50 of 183
Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Seoul (Microwave ablation)
Active, not recruiting
- Carcinoma, Hepatocellular
- +3 more
- Microwave ablation
-
Seoul, Korea, Republic ofSamsung Medical Center
Jan 23, 2023
ICU Delirium Trial (Beer)
Recruiting
- ICU Delirium
- Beer
- Water
-
Basel, SwitzerlandUniversity Hospital Basel
Jan 31, 2023
Helicobacter Pylori Infection in Patients With Chronic Tonsillits Trial in Sohag (Rapid urease test for h pylori)
Recruiting
- Helicobacter Pylori Infection in Patients With Chronic Tonsillits
- Rapid urease test for h pylori
-
Sohag, EgyptSohag university Hospital
Oct 31, 2023
B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in France, United States (XmAb13676)
Recruiting
- B-cell Non-Hodgkins Lymphoma
- Chronic Lymphocytic Leukemia
- XmAb13676
-
La Jolla, California
- +21 more
Oct 20, 2021
Takecab for "Supplement to Helicobacter Pylori Eradication"
Completed
- Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other
- Vonoprazan
- +3 more
-
Tokyo, JapanTakeda Selected Site
Dec 25, 2018
Helicobacter Pylori Infection Trial in Changsha (Saccharomyces Boulardii 250 MG, Ilaprazole.Doxycycline. Furazolidone. Colloidal
Recruiting
- Helicobacter Pylori Infection
- Saccharomyces Boulardii 250 MG
- Ilaprazole.Doxycycline. Furazolidone. Colloidal Bismuth Tartrate
-
Changsha, Hunan, ChinaThe Third Xiangya Hospital of Central South University
Jan 11, 2022
Underage Drinking, Alcohol Use, Underage Trial in Clifton (Parenting Now, Active Control Materials)
Completed
- Underage Drinking
- Alcohol Use, Underage
- Parenting Now
- Active Control Materials
-
Clifton, New JerseyREAL Prevention, LLC
Sep 15, 2022
MALT Trial in Worldwide (chlorambucil (drug), rituximab+chlorambucil, rituximab)
Completed
- Lymphoma, Mucosa-Associated Lymphoid Tissue
- chlorambucil (drug)
- +2 more
-
Antwerpen, Belgium
- +74 more
Mar 1, 2019
Consequences of Obstetric Anal Sphincter Injuries on Maternal
Not yet recruiting
- Obstetric Complication
- +6 more
-
London, Brent, United KingdomLondon Northwest Healthcare NHS Trust
Jun 28, 2023
Biological Insights of First Relapsed-refractory Mantle Cell
Not yet recruiting
- Mantle Cell Lymphoma
-
Milano, MI, Italy
- +29 more
Nov 11, 2021
Alcoholic Liver Disease, Liver Cirrhosis, Alcoholic, Probiotics Trial in Odense (Profermin Plus, FSMP, probiotics, Fresubin,
Active, not recruiting
- Alcoholic Liver Disease
- +3 more
- Profermin Plus, FSMP, probiotics
- Fresubin, dietary supplement
-
Odense, Fyn, Denmark
- +1 more
Aug 18, 2022
Growth Disorders Trial
Not yet recruiting
- Growth Disorders
- (no location specified)
Sep 15, 2021
IgA Nephropathy at High Risk of Developing ESRD Trial in Beijing (The Yi-Qi-Qing-Jie herbal compound, Immunosuppressants,
Recruiting
- IgA Nephropathy at High Risk of Developing ESRD
- The Yi-Qi-Qing-Jie herbal compound
- +3 more
-
Beijing, Beijing, ChinaGuang anmen Hospital, China Academy of Chinese Medical Sciences
Mar 15, 2022
Sjogren's Syndrome, Autoimmune Diseases Trial in Hangzhou (Assigned Interventions CD19/BCMA CAR T-cells)
Recruiting
- Sjogren's Syndrome
- Autoimmune Diseases
- Assigned Interventions CD19/BCMA CAR T-cells
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 11, 2021
Microbiota, Overweight and Obesity, Metabolic Complication Trial in Bari (Placebo, SuperFood)
Completed
- Microbiota
- +2 more
- Placebo
- SuperFood
-
Bari, BA, ItalyDepartment of Biomedical Sciences and Human Oncology - Clinica m
Jul 6, 2022
Underage Drinking, Driving Under the Influence, Drinking, Teen Trial in University Park (P-Chat, PBI, P-Chat+)
Recruiting
- Underage Drinking
- +3 more
- P-Chat
- +2 more
-
University Park, PennsylvaniaPenn State University
Oct 7, 2022
Mental Illness Trial in Jessheim, Lillestrøm (Medication free treatment, Treatment as usual Myrvegen, Treatment as usual Åråsen)
Active, not recruiting
- Mental Illness
- Medication free treatment
- +2 more
-
Jessheim, Norway
- +1 more
Aug 26, 2022